Liquidia Corp

Liquidia Corp Stock

31.39P/E
€4.65BMarket capitalisation
-US$1.05Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Liquidia Corp is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the Liquidia Corp stock.

Market capitalisation
€4.65B
P/E
31.39
P/B
-195.80
P/S
8.06
P/CF
15.07
Issued shares 90M Units

Return

Here you can see the performance of the Liquidia Corp stock.

PeriodPerfor­mance
1 Week-3.74 %
1 Month+62.62 %
3 Months-54.38 %
6 Months-8.77 %
1 Year+53.04 %
YTD+5.21 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Liquidia Corp share.

DateRatio
No data available.

Which ETF contains the Liquidia Corp stock?

The Liquidia Corp stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Liquidia Corp has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Liquidia Corp stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.